OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comparative In Vitro Activity of Ceftolozane/Tazobactam against Clinical Isolates of Pseudomonas aeruginosa and Enterobacterales from Five Latin American Countries
Juan Carlos García-Betancur, Elsa De La Cadena, María F. Mojica, et al.
Antibiotics (2022) Vol. 11, Iss. 8, pp. 1101-1101
Open Access | Times Cited: 6
Juan Carlos García-Betancur, Elsa De La Cadena, María F. Mojica, et al.
Antibiotics (2022) Vol. 11, Iss. 8, pp. 1101-1101
Open Access | Times Cited: 6
Showing 6 citing articles:
Mutational Analysis of Colistin-Resistant Pseudomonas aeruginosa Isolates: From Genomic Background to Antibiotic Resistance
Telma de Sousa, Hsin‐Yao Wang, Ting‐Wei Lin, et al.
Pathogens (2025) Vol. 14, Iss. 4, pp. 387-387
Open Access
Telma de Sousa, Hsin‐Yao Wang, Ting‐Wei Lin, et al.
Pathogens (2025) Vol. 14, Iss. 4, pp. 387-387
Open Access
Activity of ceftolozane/tazobactam and imipenem/relebactam against Gram-negative clinical isolates collected in Mexico—SMART 2017–2021
James A. Karlowsky, Sibylle Lob, Fakhar Siddiqui, et al.
JAC-Antimicrobial Resistance (2024) Vol. 6, Iss. 3
Open Access | Times Cited: 1
James A. Karlowsky, Sibylle Lob, Fakhar Siddiqui, et al.
JAC-Antimicrobial Resistance (2024) Vol. 6, Iss. 3
Open Access | Times Cited: 1
Molecular mechanisms leading to ceftolozane/tazobactam resistance in clinical isolates of Pseudomonas aeruginosa from five Latin American countries
María F. Mojica, Elsa De La Cadena, Rafael Ríos, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 7
María F. Mojica, Elsa De La Cadena, Rafael Ríos, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 7
Satisfactory In Vitro Activity of Ceftolozane–Tazobactam against Carbapenem-Resistant Pseudomonas aeruginosa But Not against Klebsiella pneumoniae Isolates
Alicja Sękowska, Marta Grabowska, Tomasz Bogiel
Medicina (2023) Vol. 59, Iss. 3, pp. 518-518
Open Access | Times Cited: 2
Alicja Sękowska, Marta Grabowska, Tomasz Bogiel
Medicina (2023) Vol. 59, Iss. 3, pp. 518-518
Open Access | Times Cited: 2
Impact of Antimicrobial Therapy on Mortality and Readmission in Multidrug-Resistant Pseudomonas Infections: A Retrospective Study at Dammam Medical Complex
Arwa H. M. AL–Saeed, Abdulaziz Almomen, Ali Jawad, et al.
Cureus (2024)
Open Access
Arwa H. M. AL–Saeed, Abdulaziz Almomen, Ali Jawad, et al.
Cureus (2024)
Open Access
Ceftolozane/Tazobactam In-Vitro Activity against Clinical Isolates from Complicated Intra-Abdominal Infection Patients in Three Indonesian Referral Hospitals
Anis Karuniawati, Merry Ambarwulan, Selvi Nafisa Shahab, et al.
Antibiotics (2022) Vol. 12, Iss. 1, pp. 52-52
Open Access | Times Cited: 2
Anis Karuniawati, Merry Ambarwulan, Selvi Nafisa Shahab, et al.
Antibiotics (2022) Vol. 12, Iss. 1, pp. 52-52
Open Access | Times Cited: 2
